SCHEMBL3105301

SCHEMBL3105301

O=C(c1ccc(Cl)cc1)N1CC(O)C(N2CCN(c3ccc(Cl)cn3)CC2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.49
MGLL Q99685 2/20 0.44
RAB9A P51151 1/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
DPP4 P27487 1/20 0.43
HTR1A P08908 2/20 0.43
DRD2 P14416 2/20 0.43
DRD4 P21917 2/20 0.43
HTR2A P28223 2/20 0.43
HTR2C P28335 2/20 0.43
HTR7 P34969 2/20 0.43
DRD3 P35462 2/20 0.43
TMEM97 Q5BJF2 2/20 0.43
SIGMAR1 Q99720 2/20 0.43
SLC6A7 Q99884 1/20 0.42
PANK3 Q9H999 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13157889 1.00 NAMPT (0.49) NAMPTMGLLRAB9AMEN1CYP1A2
SCHEMBL1257373 0.89 NAMPT (0.49) NAMPTMGLLMEN1CYP1A2CYP2C9
SCHEMBL6373486 0.89 NAMPT (0.49) NAMPTMGLLMEN1CYP1A2CYP2C9
SCHEMBL13157957 0.86 SLC6A7 (0.53) NAMPTSLC6A7ALDH1A1MAPTHTT
SCHEMBL3108298 0.86 SLC6A7 (0.53) NAMPTSLC6A7ALDH1A1MAPTHTT
SCHEMBL3105142 0.83 POLB (0.55) MGLLMEN1KMT2AHSD17B10ALDH1A1
SCHEMBL13158203 0.83 POLB (0.55) MGLLMEN1KMT2AHSD17B10ALDH1A1
SCHEMBL13157795 0.83 POLB (0.55) MGLLMEN1KMT2AHSD17B10ALDH1A1
Hydrochloric Acid SCHEMBL4557354 0.82 SLC6A7 (0.62) SLC6A7HSD17B10ALDH1A1LMNA
Hydrochloric Acid SCHEMBL4557356 0.82 SLC6A7 (0.62) SLC6A7HSD17B10ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399455-B2 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-03-19 US disclosed
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS ACKR3, CCR5, CXCR2 NAMPT 1536/4885MGLL 2345/4885RAB9A 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.